Welcome to the GENOPOIETIC website. We are a pharmaceutical company dedicated to research and development of novel therapeutic products in the field of cancer treatments.

GENOPOIETIC develops therapeutic vaccines against a broad spectrum of cancer indications. Our autologous vaccine technology utilizes the patient’s tumor to make a therapeutic vaccine that should be able to elicit a systemic immune response against the patient's own metastasis. Our leading vaccine product candidate is MVax®, which is designed as an immunotherapy for the treatment of melanoma (skin cancer). The Company's willing is to extend this innovative approach to several solid tumor cancer types.

The Menu Company introduces our Company and Team.

The Autologous Vaccine and CMO menu describe our research commitments as well as our Contract manufacturing services.

Should you have any questions or inquiries, do not hesitate to contact us and share your suggestions with us.